印度减肥药销售在仿制药初期激增后放缓
2026-07-08 07:55:26
据彭博社报道，印度肥胖与糖尿病药物市场的增长正在失去动能。报道称，在仿制司美格鲁肽产品上市引发销售短期激增仅数月后，减肥药销售增速已放缓。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
股票市场 | 欧盟法院：苹果iMessage申诉不可受理
